SCHEMBL803457

SCHEMBL803457

Cc1cc(N2CCC(N(C)Cc3ccccc3)CC2)cc(C)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.50
CHRM1 P11229 1/20 0.50
HRH1 P35367 1/20 0.50
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CHIA Q9BZP6 1/20 0.44
MCHR1 Q99705 1/20 0.43
GRIN2B Q13224 1/20 0.43
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTR1D P28221 3/20 0.41
HTR1B P28222 3/20 0.41
RORC P51449 1/20 0.41
F10 P00742 1/20 0.41
AGTR2 P50052 2/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5543151 0.80 MCHR1 (0.48) CYP2D6CHRM1HRH1CNR1CNR2
SCHEMBL7310386 0.78 MCHR1 (0.50) CYP2D6CHRM1HRH1CNR1CNR2
SCHEMBL803946 0.77 KDM4E (0.51) CYP2D6CHRM1HRH1CNR1CNR2
SCHEMBL467367 0.75 MCHR1 (0.47) CYP2D6CHRM1HRH1CNR1CNR2
SCHEMBL3956758 0.75 MCHR1 (0.61) MCHR1RORCAGTR2
SCHEMBL8442356 0.75 KDM4E (0.68) ALDH1A1KDM4EGRIN2BKMT2AAGTR2
SCHEMBL22878155 0.75 GRIN2B (0.52) CYP2D6CHRM1HRH1ALDH1A1KDM4E
SCHEMBL3375289 0.74 GRIN2B (0.61) ALDH1A1KDM4EGRIN2B
Hydrochloric Acid SCHEMBL7339715 0.74 MCHR1 (0.47) CYP2D6CHRM1HRH1CNR1CNR2
Fumaric Acid SCHEMBL9451679 0.74 SIGMAR1 (0.52) CNR1CNR2ALDH1A1MCHR1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
WO-2012038081-A1 SUBSTITUTED BENZAMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-03-29 WO disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 CYP2D6 900/4885CHRM1 117/4885HRH1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.